Date: June 9, 2021
Health Canada has released an important labelling update about the use of non-steroidal anti-inflammatory drugs (NSAIDs).
The issue is the use of non-steroidal anti-inflammatory drugs beyond 20 weeks of pregnancy and risk of kidney damage to unborn babies leading to low amniotic fluid.
Health Canada is now advising pregnant women not use NSAIDs from 20 to 28 weeks of pregnancy, unless advised by a healthcare professional, due to risk of kidney damage and low amniotic fluid.
The SOGC will continue to monitor and advise on any updates from Health Canada.